Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

AM-694

This article is a stubmissing:
Subjective Effects
Pharmacology
Interactions
Tolerance
History & Culture
AM-694 molecule structureAM-694 molecule structure
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole
Warrior Ultimate, Pulse Ultra, Shamrock
Psychoactive Class
CannabinoidHallucinogen

Dosage & Duration

Duration

Onset5 minutes
Total2 hours

Subjective Effects

Subjective Effects not written up yet

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Liebermann(LB)
white → yellow3
Powered by PROtestkit.eu

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Toxicity

Systemic

Oral administration may produce the highly toxic metabolite fluoroacetic acid, posing significant systemic toxicity risk; this route of administration should be strictly avoided.

History & Culture

History & Culture not written up yet

Legality

By Country

Controlled / restricted1
Finland flagFinlandRestricted

References

Source Pages

  1. Bluelight forum: AM-694 and smoking blends WARNING (2010)
  2. Drug Users Bible by Dominic Milton Trott
  3. Drug Users Bible: AM-694
  4. Wikipedia

Citations

  1. Valtioneuvoston asetus 1130/2014, ajantasainen liite (25.6.2026/650). finlex.fi (n.d.). https://www.finlex.fi/api/media/statute-consolidated/1079343/media/8500.pdf1
  2. Valtioneuvoston asetus kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista 1130/2014, ajantasainen säädös. finlex.fi (n.d.). https://www.finlex.fi/fi/lainsaadanto/2014/11301
  3. Huumausainelaki 373/2008, ajantasainen säädös, 3 §, 5 § and 23 b §. finlex.fi (n.d.). https://www.finlex.fi/fi/lainsaadanto/2008/3731
  4. Valtioneuvoston asetus 1130/2014 kuluttajamarkkinoilta kielletyistä psykoaktiivisista aineista. finlex.fi (n.d.). https://www.finlex.fi/api/media/statute/87257/mainPdf/main.pdf1

Further Reading

  1. Donohue BL et al. Synthesis and biological evaluation of AM-694 (2008)
  2. Donohue SR et al. Preclinical evaluation of [18F]AM-694 as CB1 PET imaging agent (2009)
  3. EMCDDA: Europol 2011 Report on AM-694
  4. Grigoryev et al. Detection of urinary metabolites of AM-694 (2013)
  5. PubChem: Compound Summary for CID 10491092 (AM-694)

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the AM-694 article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.